IMMX

Immix Biopharma Inc

May 18 • 10:49AM ET

9.59

-0.35 -3.52 %

Healthcare • Biotechnology • USA • Small • NASD

Peers: COGT NUVB CCCC KURA FATE

| Held by: VTI VXF IWC AVSC

Scroll to Statements

Index	-	P/E	-	EPS (ttm)	-0.92	Insider Own	24.92%	Shs Outstand	53.01M	Perf Week	-3.33%
Market Cap	521.81M	Forward P/E	-	EPS next Y	-0.71	Insider Trans	0.01%	Shs Float	40.87M	Perf Month	-7.34%
Enterprise Value	432.27M	PEG	-	EPS next Q	-0.18	Inst Own	49.10%	Short Float	7.39%	Perf Quarter	18.10%
Income	-34.98M	P/S	-	EPS this Y	17.08%	Inst Trans	67.97%	Short Ratio	4.04	Perf Half Y	165.65%
Sales	0.00M	P/B	6.03	EPS next Y	3.79%	ROA	-60.47%	Short Interest	3.02M	Perf YTD	83.37%
Book/sh	1.59	P/C	5.76	EPS next 5Y	39.20%	ROE	-74.47%	52W High	11.61 -17.40%	Perf Year	365.53%
Cash/sh	1.66	P/FCF	-	EPS past 3/5Y	-12.81% -43.32%	ROIC	-41.02%	52W Low	1.87 412.83%	Perf 3Y	402.09%
Dividend Est.	-	EV/EBITDA	-	Sales past 3/5Y	- -	Gross Margin	-	Volatility	6.87% 7.67%	Perf 5Y	-
Dividend TTM	-	EV/Sales	-	EPS Y/Y TTM	-27.17%	Oper. Margin	-	ATR (14)	0.73	Perf 10Y	-
Dividend Ex-Date	-	Quick Ratio	8.76	Sales Y/Y TTM	-	Profit Margin	-	RSI (14)	49.03	Recom	1.00
Dividend Gr. 3/5Y	- -	Current Ratio	8.76	EPS Q/Q	-19.16%	SMA20	-1.25%	Beta	0.13	Target Price	18.25
Payout	-	Debt/Eq	0.01	Sales Q/Q	-	SMA50	0.04%	Rel Volume	0.50	Prev Close	9.94
Employees	21	LT Debt/Eq	0.01	Earnings	Feb 25	SMA200	70.95%	Avg Volume	748.48K	Price	9.59
IPO	Dec 16, 2021	Option/Short	Yes / Yes	EPS/Sales Surpr.	-83.03% -	Trades		Volume	89,841	Change	-3.52%

Affiliate • Advertise • Careers • Contact • Blog • Help • Privacy • Follow us on X • Do Not Sell My Personal Information

Quotes delayed 15 minutes for NASDAQ, NYSE and AMEX.
Copyright © 2007-2026 Finviz.com. All Rights Reserved. Export All Screener Data (CSV)